Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study
Orrú CD. et al, (2025), Lancet Neurology, 24, 580 - 590
The gut–brain axis in early Parkinson’s disease: from prodrome to prevention
Oliver PJ. et al, (2025), Journal of Neurology, 272
Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorder.
Joza S. et al, (2025), EBioMedicine
The profile of gastrointestinal dysfunction in prodromal to late-stage Parkinson's disease.
Camacho M. et al, (2025), NPJ Parkinsons Dis, 11
Working memory filtering at encoding and maintenance in healthy ageing, Alzheimer’s and Parkinson’s disease
Toniolo S. et al, (2025), Scientific Reports, 15
Cholinergic degeneration in prodromal and early Parkinson’s: a link to present and future disease states
Eisenstein T. et al, (2025), Brain
Automated quality control of T1-weighted brain MRI scans for clinical research datasets: methods comparison and design of a quality prediction classifier
Bhalerao G. et al, (2025), Imaging Neuroscience
Cognitive and neuropsychiatric profiles distinguish atypical parkinsonian syndromes.
Hu MT. et al, (2025), Brain
Association of cholesterol and glycemic state biomarkers with phenotypic variation and Parkinson's disease progression: The Oxford Discovery cohort.
Ho Chiu NK. et al, (2025), J Parkinsons Dis
Single extracellular vesicle detection assay identifies membrane-associated α-synuclein as an early-stage biomarker in Parkinson’s disease
Yan S. et al, (2025), Cell Reports Medicine, 6, 101999 - 101999
LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization
Chahine LM. et al, (2025), Brain Communications, 7
Neuroimaging-based data-driven subtypes of spatiotemporal atrophy due to Parkinson's disease.
Shawa Z. et al, (2025), Brain Commun, 7
Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease
Sauerbier A. et al, (2024), npj Parkinson's Disease, 10
A worldwide study of subcortical shape as a marker for clinical staging in Parkinson's disease.
Laansma MA. et al, (2024), NPJ Parkinsons Dis, 10
Evaluation of Cerebrospinal Fluid α-Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome.
Vaughan DP. et al, (2024), Mov Disord
A worldwide study of white matter microstructural alterations in people living with Parkinson's disease.
Owens-Walton C. et al, (2024), NPJ Parkinsons Dis, 10
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.
Westenberger A. et al, (2024), Brain, 147, 2652 - 2667
Genome sequence analyses identify novel risk loci for multiple system atrophy.
Chia R. et al, (2024), Neuron, 112, 2142 - 2156.e5